Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/5/26 17:20 | 10/1/26 | PALI | Health | BioPrd | Biological Products, (No Diag | Williams Donald Allen | CO | D | P.m | 29 | 1.44 | 0 | 20 | 1 | 1,593 | D | |||||||||||||||
7/10/26 18:14 | 7/8/26 | PALI | Health | BioPrd | Biological Products, (No Diag | Baltera Robert Jr. | CO | D | P.m | 89 | 1.97 | 0 | 45 | 11 | 462 | D | |||||||||||||||
7/8/26 18:56 | 7/6/26 | PALI | Health | BioPrd | Biological Products, (No Diag | Baltera Robert Jr. | CO | D | P.m | 102 | 2.04 | 0 | 50 | 14 | 417 | D | |||||||||||||||
7/6/26 19:48 | 7/1/26 | PALI | Health | BioPrd | Biological Products, (No Diag | Baltera Robert Jr. | CO | D | P.m | 59 | 1.98 | 0 | 30 | 9 | 367 | D | |||||||||||||||
1/21/26 16:05 | 1/16/26 | PALI | Health | BioPrd | Biological Products, (No Diag | Williams Donald Allen | CA | D | P | 8 | 1.67 | 0 | 5 | 57 | 14 | D | |||||||||||||||
1/13/26 21:43 | 1/9/26 | PALI | Health | BioPrd | Biological Products, (No Diag | Williams Donald Allen | CA | D | P | 9 | 1.88 | 0 | 5 | 134 | 9 | D | |||||||||||||||
5/29/24 15:47 | 5/28/24 | PALI | Health | BioPrd | Biological Products, (No Diag | Williams Donald Allen | CA | D | P | 5 | 4.86 | 0 | 1 | 50 | 3 | D | |||||||||||||||
5/28/24 06:02 | 5/24/24 | PALI | Health | BioPrd | Biological Products, (No Diag | Finley John David | CA | DO | CEO,CFO, | P | 5 | 4.81 | 0 | 1 | 13 | 8 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |